CMMB

Chemomab Therapeutics Is Heating Up And Could See A Move Soon

Chemomab Announces Poster Presentation at the International Liver Congress 2021 (EASL)

Chemomab Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update

Chemomab to Present at Oppenheimer's Virtual Rare and Orphan Disease Summit

Chemomab Announces Enrollment of First Patient in Phase 2a Study of CM-101 in Non-Alcoholic Steatohepatitis (NASH)

Chemomab Therapeutics Stock Price Increased 111.13%: Why It Happened